# Product Roadmap

**Reading Time:** ~12 minutes
**Audience:** Executives, product leaders
**Prerequisites:** [Business Value](02-business-value.md)
**Goal:** Understand Observer's strategic direction and planned enhancements

---

## Vision

**Observer as the definitive emotional intelligence platform:**

- Most accurate emotion recognition (87 emotions)
- Best therapeutic guidance (evidence-based pathfinding)
- Deepest historical insights (vector search patterns)
- Most trusted by clinicians (research validated)

---

## Current Capabilities (v1.0)

### Core Features ✅

- **87-Emotion Atlas** - Brené Brown's Atlas of the Heart
- **VAC Model** - 3D emotional space (Valence, Arousal, Connection)
- **Vector Search** - Find similar past moments
- **A* Pathfinding** - Therapeutic transition paths
- **69 Strategies** - Evidence-based interventions (ACT, DBT, CBT)
- **Real-time Chat** - WebSocket-based guidance
- **Temporal Metrics** - Elasticity and rigidity
- **Clinical Alerts** - Risk detection

### Performance ✅

- API latency: 78ms P95 (target: < 100ms)
- Vector search: 5ms (1M vectors)
- Uptime: 99.95%
- Scale: 10K concurrent users

---

## Q1 2026: Clinical Validation & Polish

**Focus:** Prove therapeutic efficacy

### Features

**1. Enhanced Insight Quality** (January)

- Multi-emotion analysis (detect complex states)
- Contradiction detection ("I'm happy but also sad")
- Contextual depth scoring

**2. Clinical Dashboard** (February)

- Therapist portal for client monitoring
- Aggregated insights (no PHI exposure)
- Outcome tracking
- Therapeutic validity metrics

**3. Research Study** (March)

- 50-100 pilot users with therapists
- Validated outcome measures
- IRB approval
- 8-week study duration

**Deliverables:**

- Clinical validation report
- Therapist testimonials
- Published case studies

---

## Q2 2026: Intelligence & Personalization

**Focus:** Leverage AI/ML for better insights

### Features

**1. ML-Optimized Fusion** (April)

- Learn optimal weights from labeled data
- Improve emotion matching accuracy from 91% → 95%+
- A/B test with current heuristic

**2. Pattern Recognition** (May)

- Detect weekly/monthly cycles (FFT analysis)
- Identify triggers ("anxiety spikes on Mondays")
- Predict emotional trends

**3. Personalized Strategies** (June)

- Rank strategies by user effectiveness
- Learn from user feedback ("this helped" / "didn't help")
- Adaptive recommendations

**Metrics:**

- Emotion matching accuracy: 91% → 95%
- Strategy effectiveness: +20%
- User satisfaction: +15%

---

## Q3 2026: Scale & Expansion

**Focus:** Reach more users, more ways

### Features

**1. Multi-Language Support** (July)

- Spanish translation (atlas + strategies)
- Mandarin translation
- Emotion embeddings in multiple languages

**2. Mobile SDK** (August)

- React Native components
- Offline support (local cache, sync later)
- Push notifications for check-ins

**3. Integration APIs** (September)

- Public API for third-party apps
- Webhooks for real-time events
- OAuth for authentication
- Rate limiting and quotas

**Growth targets:**

- 10K → 50K users
- 3 new languages
- 5 integration partners

---

## Q4 2026: Enterprise & Collaboration

**Focus:** B2B revenue, collaborative features

### Features

**1. Therapist Tools** (October)

- Client trajectory viewer
- Session notes integration
- Outcome measurement tools
- Billing integration

**2. Enterprise Features** (November)

- Multi-user organizations
- Team emotional health dashboards
- Department-level analytics (anonymized)
- Stress pattern alerts for managers

**3. Collaborative Journeys** (December)

- Couples emotional tracking
- Relationship patterns
- Synchronized paths
- Therapist-guided group work

**Revenue targets:**

- 10 enterprise customers @ $5K/month = $50K MRR
- 50 therapists @ $49/month = $2.5K MRR
- Total B2B: $52.5K MRR

---

## 2027: Research & Innovation

**Focus:** Academic validation, advanced AI

### Major Initiatives

### 1. Research Publication (Q1)

- Peer-reviewed paper on VAC model
- Clinical validation study results
- Pathfinding efficacy data
- Target: JMIR, Cyberpsychology journal

**2. Reinforcement Learning** (Q2)

- Train RL agent on pathfinding
- Learn from user success/failure
- Potentially better than A* for personalization

**3. Graph Neural Networks** (Q3)

- Model emotion relationships as graph
- Learn category transition rules
- Discover new bridge emotions

**4. Longitudinal Analysis** (Q4)

- Multi-year trajectory patterns
- Life event correlation
- Developmental emotional changes
- Resilience quantification

---

## 2028: Platform Maturity

**Focus:** Market leadership, ecosystem

### Vision

**Observer becomes:**

- **Standard** for digital emotional intelligence
- **Required** for mental health apps (like Stripe for payments)
- **Trusted** by clinicians and researchers
- **Scaled** to millions of users

### Features

#### 1. Observer Platform

- API for any app to add emotional intelligence
- White-label options
- SDK for major platforms (iOS, Android, Web, Unity)

#### 2. Research Tools

- Anonymized data access for researchers
- Grant-funded studies
- Academic partnerships

#### 3. Global Scale

- 20+ languages
- Cultural emotion variations
- Regional therapeutic strategies

#### 4. Advanced AI

- Predictive emotional forecasting
- Intervention timing optimization
- Automated therapeutic protocol generation

---

## Research Priorities

### Ongoing

- VAC model validation across cultures
- Long-term outcome tracking
- Therapeutic efficacy studies
- User experience optimization

### Future

- Emotion prediction (forecast next state)
- Automated journal prompts
- Voice-based emotion detection
- Physiological integration (HRV, sleep)

---

## Technology Evolution

### 2026

- PostgreSQL + pgvector (current)
- Python/FastAPI
- Single region deployment

### 2027

- Distributed caching (Redis)
- Read replicas (analytics)
- Multi-region deployment

### 2028

- Graph database for relationships (Neo4j?)
- Real-time ML inference
- Edge deployment for offline mode

---

## Success Milestones

### User Metrics

**2026:**

- 50K active users
- 12% premium conversion
- 70% weekly retention

**2027:**

- 250K active users
- 15% premium conversion
- 75% weekly retention

**2028:**

- 1M active users
- 18% premium conversion
- 80% weekly retention

### Revenue Milestones

**2026:** $1M ARR
**2027:** $5M ARR
**2028:** $20M ARR

### Clinical Milestones

**2026:** 1 published case study
**2027:** 1 peer-reviewed publication
**2028:** 3+ published studies, clinician adoption

---

## Strategic Decisions

### Build vs. Buy

**Built in-house:**

- ✅ Core algorithms (A*, weighted fusion)
- ✅ VAC model implementation
- ✅ Atlas integration
- ✅ Pathfinding system

**Considering external:**

- 🤔 Embedding service (OpenAI vs. local)
- 🤔 Analytics platform (Amplitude vs. custom)
- 🤔 Infrastructure (managed vs. self-hosted)

### Open Source vs. Proprietary

**Open source:**

- 📖 Documentation (you're reading it!)
- 📖 Research papers
- 📖 Educational content

**Proprietary:**

- 🔒 VAC coordinates (trade secret)
- 🔒 Weighted fusion formula (patent pending)
- 🔒 Category transition rules
- 🔒 Production infrastructure

---

## Investment Needs

### Q1-Q2 2026 ($500K)

- Engineering team expansion (3 → 5 engineers)
- Clinical validation study
- Security certifications (HIPAA)

### Q3-Q4 2026 ($1M)

- Sales team (2 AEs, 1 SE)
- Marketing (content, ads)
- Infrastructure scaling

### 2027 ($2M+)

- Engineering team (5 → 10 engineers)
- Research team (2 clinical researchers)
- International expansion

---

## Next Steps

**For executives:**

- Approve roadmap priorities
- Allocate budget for Q1-Q2
- Champion clinical partnerships

**For product:**

- Prioritize Q1 features
- Coordinate with engineering
- Plan user research

**For engineering:**

- Review [Manager: Architecture](../architecture/00-high-level-overview.md)
- Estimate Q1 features

---

**Questions?** Contact Product Leadership or request detailed technical roadmap.
